Abstract:Following the publication of the above article, an interested reader drew to the authors' attention that Fig. 4A on p. 921, showing the results from cell migration assay experiments, featured a pair of duplicated data panels. After having consulted their original data, the authors have realized that Fig. 3A on the same page, showing the fluorometric images of apoptotic cells, also contained a pair of duplicated data panels. These errors in the presentation of these figures arose inadvertently as a consequence of selecting the wrong images for the 'RA NC' data panel in Fig. 3A and the NOR-FLS data panel in Fig. 5E. The revised versions of Figs. 3 and 4 are shown on the next two pages. All the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret their oversight in allowing these errors to be included in the paper, and also apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 11: 917‐923, 2015; DOI: 10.3892/mmr.2014.2770]

Erratum to: Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients

Erratum to: Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis

Erratum to: Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus

Erratum to: Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis

Erratum to: Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?

Erratum: VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis

Erratum: Serum vitamin D and antinuclear antibody level in oral lichen planus patients: A cross-sectional study: Erratum

Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

Erratum: Addendum of Conflict of Interest

Erratum to: Contributing Factors of Diabetes Mellitus among Patients with Gout (Results of the Long-Term Prospective Study)

Comment on Editorial ‘pathogenic Effector Functions of ACPA: Where Do We Stand?’

Erratum: Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention

Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity

Erratum to: "Amphipathic CRAC-Containing Peptides Derived from the Influenza Virus A M1 Protein Modulate Cholesterol-Dependent Activity of Cultured IC-21 Macrophages" [Biochemistry (Moscow), 83, 982 (2018)]

Erratum: Asymptomatic Erythematous and Tan, Shiny, Well-Defined Plaques: Erratum

Erratum to: Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus Erythematosus

Correction to: Autoinflammatory diseases: why they should matter to the dermatologist

Erratum: Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia

[Corrigendum] Role of cysteine‐rich angiogenic inducer 61 in fibroblast‐like synovial cell proliferation and invasion in rheumatoid arthritis

Corrigendum to Retrospective Analysis in Patients With Moderate to Severe Plaque Psoriasis Treated With Tildrakizumab: Real-Life Clinical Data